National Cancer Institute (NCI) Symposium: BRD4, a Central Player in Cancer and Immune Responses

National Cancer Institute (NCI) Symposium: BRD4, a Central Player in Cancer and Immune Responses

Chairs:
Devaiah Ballachanda, NCI, NIH
T. Kevin Howcroft, NCI, NIH

Speakers:

• Dinah S. Singer, NCI, NIH, BRD4, linking chromatin structure and transcription
• Cheng-Ming Chiang, Univ. of Texas Southwestern Med. Ctr., BRD4 in gene-specific targeting and cancer therapeutics
• Rugang Zhang, Wistar Inst., BRD4 and antitumor immunity in ovarian cancer
• Gerald V. Denis, Boston Univ. Sch. of Med., BET bromodomain proteins couple microenvironment cytokines to breast cancer progression